Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
YGNvYrhTegMEhy1K
Listen
